What is BioInformatics?
BioInformatics Inc. operates as a specialized intelligence hub, delivering essential quantitative and qualitative data to suppliers within the analytical instrument and life science industries. The firm distinguishes itself by maintaining a vast, active community of scientists, which serves as a primary source for its customized consulting and market research services. Through a combination of industry-leading reports, newsletters, and analytical tools, the company enables its clients to navigate complex market dynamics and align their product development strategies with the evolving needs of the global scientific community. Their business model effectively bridges the gap between raw laboratory data and actionable commercial strategy.
How much funding has BioInformatics raised?
BioInformatics has raised a total of $21M across 1 funding round:
Series B
$21M
Series B (2018): $21M, investors not publicly disclosed
Key Investors in BioInformatics
BioInformatics
Undisclosed investor participating in the funding round.
What's next for BioInformatics?
With the successful closure of this major strategic investment, BioInformatics is poised to accelerate its growth trajectory by expanding its suite of digital intelligence tools. The company is expected to focus on enhancing its data analytics capabilities, allowing for more granular insights into the clinical diagnostic market. Furthermore, the infusion of capital will likely support the scaling of their research infrastructure, ensuring that their community of 55,000 scientists remains a robust engine for market discovery. As the life sciences sector continues to undergo rapid technological transformation, BioInformatics is strategically positioned to remain the primary source of truth for suppliers seeking to maintain a competitive edge in a high-stakes global environment.
See full BioInformatics company page
